Get started
Author

Sophia Delicou

Observed names: Delicou, Sophia, S Delicou, S Sophia Delicou, S. Delicou, S.D. Delicou, SOPHIA DELICOU
ORCID: 0000-0002-7049-6131
Observed ORCID: 0000-0002-7049-6131
OpenAlex ID: A5016590499
Successful HLA‐identical hematopoietic stem cell transplantation in a patient with purine nucleoside phosphorylase deficiency
2007 · Sophia Delicou, Vassiliki Kitra‐Roussou, et al. · Pediatric Transplantation · 31
PDF
Genetic Modifiers of Hemoglobin Expression from a Clinical Perspective in Hemoglobinopathy Patients with Beta Thalassemia and Sickle Cell Disease
2024 · Michael D. Diamantidis, Georgia Ikonomou, et al. · International Journal of Molecular Sciences · 18
Clinical significance of mutational variants in beta and alpha genes in patients with hemoglobinopathies from two large Greek centers: a complex interplay between genotype and phenotype
2023 · Michael D. Diamantidis, Rebecca-Anastasia Karanikola, et al. · Journal of Molecular Medicine · 16
PDF
Stroke and presence of patent foramen ovale in sickle cell disease
2021 · Constantina Aggeli, Kali Polytarchou, et al. · Journal of Thrombosis and Thrombolysis · 14
PDF
Twelve‐lead and signal‐averaged electrocardiographic parameters among beta‐thalassemia major patients
2020 · Dimitrios Patsourakos, Konstantinos A. Gatzoulis, et al. · Journal of Arrhythmia · 12
PDF
Severity of heart failure and health-related quality of life in beta-thalassemia patients: a cross-sectional study
2020 · Yannis Dimitroglou, Fotios Anagnostopoulos, et al. · Annals of Hematology · 10
Disorders of the erythrocyte membrane
2015 · Sophia Delicou, Aikaterini Xydaki, et al. · Italian Journal of Medicine · 10
PDF
Transient Elastography (te) Is a Useful Tool for Assessing the Response of Liver Iron Chelation in Sickle Cell Disease Patients
2018 · SOPHIA DELICOU · Mediterranean Journal of Hematology and Infectious Diseases · 9
PDF
Comparative analysis of mortality patterns and treatment strategies in thalassaemia and sickle cell disease patients: A 12‐year study
2025 · Sophia Delicou, Konstantinos Manganas, et al. · British Journal of Haematology · 8
Cellular and biochemical heterogeneity contributes to the phenotypic diversity of transfusion-dependent β-thalassemia
2025 · Konstantina Theocharaki, Alkmini T. Anastasiadi, et al. · Blood Advances · 8
PDF
Predisposing factors for advanced liver fibrosis in patients with sickle cell disease
2023 · Konstantinos Manganas, Sophia Delicou, et al. · British Journal of Haematology · 8
Pain Management in Patients with Sickle Cell Disease – A Review
2013 · Sophia Delicou, Konstantinos Maragkos · EMJ Hematology · 8
PDF
Etavopivat Reduces Incidence of Vaso-Occlusive Crises in Patients with Sickle Cell Disease: HIBISCUS Trial Phase 2 Results through 52 Weeks
2024 · Sophia Delicou, Fuad El Rassi, et al. · Blood · 7
PDF
Left atrial deformation indices in β-thalassemia major patients
2022 · Dimitrios Patsourakos, Constantina Aggeli, et al. · Annals of Hematology · 7
Speckle tracking echocardiography and β-thalassemia major. A systematic review
2023 · Dimitrios Patsourakos, Constantina Aggeli, et al. · Annals of Hematology · 6
PDF
Real-World Data on the Use of Luspatercept in Greek Patients with Transfusion Dependent Thalassemia
2022 · Polyxeni Delaporta, Alexandra Kourakli, et al. · Blood · 6
The Effect of COVID-19 on Hemoglobinopathy Patients’ Daily Lives While Quarantined: Four Greek Hospitals’ Experiences
2022 · Sophia Delicou, Aikaterini Xydaki, et al. · Thalassemia Reports · 6
PDF
Adrenal Insufficiency in Patients with Beta Thalassemia: A Meta-Analysis
2024 · Christos Savvidis, Dimitra Ragia, et al. · Medicina · 5
PDF
Unveiling Extramedullary Hematopoiesis: A Case Report Highlighting the Causes, Symptoms, and Management Strategies
2024 · Konstantinos Manganas, Aikaterini Xydaki, et al. · Thalassemia Reports · 5
PDF
Real‐world complication burden and disease management paradigms in transfusion‐related β‐thalassaemia in Greece: Results from ULYSSES, an epidemiological, multicentre, retrospective cross‐sectional study
2023 · Antonis Kattamis, Ersi Voskaridou, et al. · eJHaem · 5
PDF
Hepatitis C Virus Infection, but Not Hepatic Iron Overload Is the Dominant Risk Factor for the Manifestation of Hepatocellular Carcinoma Among Greek Thalassemic Patients
2018 · Alexandra Kourakli, Michael D. Diamantidis, et al. · Blood · 5
Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion Therapy
2022 · Konstantinos Manganas, Sophia Delicou, et al. · Hemoglobin · 4
Combination of Exchange Transfusion Treatment and Hydroxyurea Cause Beneficial Changes to Laboratory Parameters and Clinical Outcome in Patients with Sickle Cell Disease/β Thalassemia Compared with Hydroxyurea or Exchange Transfusion Alone
2016 · Sophia Delicou · Hematology & Transfusion International Journal · 4
PDF
Short- and long-term effects of transfusion in β-thalassemia: a longitudinal study of transfusion efficiency factors
2025 · Konstantina Theocharaki, Ioanna Barla, et al. · Blood Advances · 3
PDF
Systematic Yersinia enterocolitica in an iron overloaded and immunocompromised thalassemic patient
2017 · Sophia Delicou, Aikaterini Petrocheilou, et al. · Microbiologia medica · 3
PDF
Works count: 85
Citation count: 247
H-index: 8
I10-index: 7
Year
Topic
Type